Results 261 to 270 of about 48,579 (345)

Effects of Video‐Based Health Education on Birth Outcomes and Anaemia Status of Mothers in Dirashe District South Ethiopia: A Cluster Randomized Controlled Trial

open access: yesMaternal &Child Nutrition, EarlyView.
ABSTRACT Undernutrition and infections during pregnancy result in low birth weight (LBW) and maternal anaemia. Social behaviour change communication (SBCC) can promote recommended health practices, potentially improving maternal and neonatal outcomes.
Wanzahun Godana Boynito   +9 more
wiley   +1 more source

Visual–spatial abilities enhancement and spatial anatomy learning: A systematic review

open access: yesMedical Education, EarlyView.
Abstract Introduction Student's visual–spatial abilities appear to be an important predictor of learning time, performance and knowledge in anatomy. The objective of this systematic review was to assess the relationship between spatial abilities enhancement and spatial learning of anatomy.
Lara Nokovitch   +5 more
wiley   +1 more source

Long‐Term Clinical and Physiological Outcomes in Patients Treated Non‐Surgically for Anorectal Malformations

open access: yesNeurogastroenterology &Motility, EarlyView.
The long‐term anorectal outcomes of non‐surgically treated patients diagnosed with minor types of ARM seem optimal. Most of these patients experience no constipation or fecal incontinence; some experience constipation and relatively seldom fecal incontinence. Furthermore, most patients possess all the known fecal continence mechanisms.
Venla E. C. den Hollander   +3 more
wiley   +1 more source

Birth and Regulation of head Extension to Guide Manual perineal Assistance (BREGMA) study: a prospective cohort study. [PDF]

open access: yesBMC Pregnancy Childbirth
Abouelhassan A   +5 more
europepmc   +1 more source

Early Evidence of Safety, Clinical Benefit, and Pharmacokinetics of Roflumilast Cream 0.3% Once Daily for Treatment of Mild or Moderate Plaque Psoriasis in Children Aged 2–11 Years

open access: yesPediatric Dermatology, EarlyView.
ABSTRACT Two 4‐week, phase 2, open‐label, maximal usage pharmacokinetic (PK) and safety studies of once‐daily roflumilast cream 0.3% (a potent phosphodiesterase 4 inhibitor) were conducted in children aged 2–5 years and 6–11 years with psoriasis. Evidence of systemic exposure to roflumilast and its active N‐oxide metabolite was seen in most patients ...
Adelaide A. Hebert   +13 more
wiley   +1 more source

Home - About - Disclaimer - Privacy